Boston Scientific CorporationBSXNYSE
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank69
Year-over-Year Change
Year-over-year book value per share growth
Percentile
P69
Within normal range
vs 2Y Ago
1.7x
Solid growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.49% |
| Q3 2025 | 4.09% |
| Q2 2025 | 0.83% |
| Q1 2025 | 1.81% |
| Q4 2024 | 4.89% |
| Q3 2024 | 1.53% |
| Q2 2024 | 2.04% |
| Q1 2024 | 3.05% |
| Q4 2023 | 2.04% |
| Q3 2023 | 2.19% |
| Q2 2023 | 1.34% |
| Q1 2023 | 2.82% |
| Q4 2022 | -0.46% |
| Q3 2022 | 2.12% |
| Q2 2022 | 2.95% |
| Q1 2022 | 0.49% |
| Q4 2021 | 0.88% |
| Q3 2021 | 3.08% |
| Q2 2021 | 1.23% |
| Q1 2021 | 3.21% |
| Q4 2020 | -2.86% |
| Q3 2020 | -2.21% |
| Q2 2020 | 14.40% |
| Q1 2020 | -0.75% |
| Q4 2019 | 42.97% |
| Q3 2019 | 2.75% |
| Q2 2019 | 1.84% |
| Q1 2019 | 5.54% |
| Q4 2018 | 5.15% |
| Q3 2018 | 6.86% |
| Q2 2018 | 9.85% |
| Q1 2018 | 0.02% |
| Q4 2017 | -7.69% |
| Q3 2017 | 4.71% |
| Q2 2017 | 2.25% |
| Q1 2017 | 4.48% |
| Q4 2016 | 3.77% |
| Q3 2016 | 3.97% |
| Q2 2016 | -4.17% |
| Q1 2016 | -2.06% |